estudio flow semaglutide trial Ozempic® (semaglutide injection) Highlights ADA 2024: Estudio FLOW

Semaglutide can be used as a tool to reach your goals, but it may be unwise to think of it as a long-term solution

HbA1c is measured in percentages

Researchers documented these milestones in uncovering the vision risks: Summer 2023: Three NAION cases presented at Mass Eye and Ear within a short period, all involving semaglutide users July 2024: Publication of the landmark Harvard study in JAMA Ophthalmology revealing increased NAION risk December 2024: Danish researchers published supporting studies involving over 424,000 patients 2025: Multiple international studies confirmed the association between semaglutide and vision problems The pivotal Harvard study analyzed medical records from 16,827 patients treated between 2017 and 2023, comparing those prescribed semaglutide against patients using other diabetes or weight loss medications

Semaglutide can cause a number of other side effects

The 0.25 mg dose is primarily a stepping stone